Abstract
Background: Interleukin‐1 receptor antagonist (IL‐1 Ra) levels are elevated early in patients with acute myocardial infarction (MI) and often precede release of markers of necrosis; however, IL‐1Ra levels did not correlate previously with infarct size and prognosis in such patients.
Hypothesis: The goal of our study was to evaluate prospectively the correlation between IL‐1Ra levels upon emergency department (ED) presentation and the extent of myocardial necrosis and prognosis in patients with ST‐segment elevation MI.
Methods: Levels of IL‐1Ra were measured upon ED presentation in 44 consecutive patients (40 men, aged 55 ± 10 years). Peak values of creatine kinase (CK) and CK‐MB were determined during hospitalization, and left ventricular ejection fraction (LVEF) was evaluated by echocardiography before discharge. All patients were followed prospectively and underwent clinical and echocardiographic assessment at 42 ± 3 months after the infarction.
Results: Levels of IL‐1Ra upon ED presentation correlated directly with CK (p = 0.002) and CK‐MB (p = 0.01) peak levels and correlated inversely with LVEF before discharge (p = 0.009). Patients with in‐hospital adverse events had significantly higher IL‐1Ra levels upon ED admission (n = 10,2620 ± 4706 pg/ml) than those without events (n = 34, 598 ± 457 pg/ml)(p = 0.015).
Conclusions: In patients with MI, levels of IL‐1Ra upon ED presentation correlated significantly with the extent of myocardial necrosis, as measured by cardiac enzymes peak and reduction of LVEF, and are predictive of in‐hospital events. Results of this study may influence early therapeutic approach in patients with acute MI.
Keywords: inflammation, interleukins, myocardial infarction, prognosis
Full Text
The Full Text of this article is available as a PDF (38.2 KB).
References
- 1. Ross R: Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126 [DOI] [PubMed] [Google Scholar]
- 2. Patti G, D'Ambrosio A, Dobrina A, Dicuonzo G, Giansante C, Fiotti N, Abbate A, Guarnieri G, Di Sciascio G: Interleukin‐1 receptor antagonist: A sensitive marker of instability in patients with coronary artery disease. J Thromb Thrombol 2002; 14: 139–143 [DOI] [PubMed] [Google Scholar]
- 3. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin (IL)‐1Ra and IL‐6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in‐hospital coronary events. Circulation 1999; 99: 2079–2084 [DOI] [PubMed] [Google Scholar]
- 4. Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A, Dobrina A: Prognostic value of interleukin‐1 receptor antagonist in patients undergoing percutaneous coronary intervention. Am J Cardiol 2002; 89: 372–376 [DOI] [PubMed] [Google Scholar]
- 5. Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A: Inflammatory markers and coronary interventions: A potentially useful follow‐up modality after stenting. Cathet Cardiovasc Int 2002; 56: 341–345 [DOI] [PubMed] [Google Scholar]
- 6. Patti G, D'Ambrosio A, Mega S, Giorgi G, Zardi EM, Zardi DM, Dicuonzo G, Dobrina A, Di Sciascio G: Early interleukin‐1 receptor antagonist elevation in patients with acute myocardial infarction. J Am Coll Cardiol 2004; 43: 35–38 [DOI] [PubMed] [Google Scholar]
- 7. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, Sato N, Arakawa N, Suzuki T, Aoki H, Suzuki T, Hiramori K: Elevated plasma levels of interleukin‐1 receptor antagonist and interleukin‐10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997; 17: 145–150 [DOI] [PubMed] [Google Scholar]
- 8. Dinarello C: Biological basis for interleukin‐1 in disease. Blood 1996; 87: 2095–2147 [PubMed] [Google Scholar]
- 9. Loppnow H, Werdan K, Reuter G, Flad HD: The interleukin‐1 and interleukin‐1 converting enzyme families in the cardiovascular system. Eur Cytokine Netw 1998; 9: 675–680 [PubMed] [Google Scholar]
- 10. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL: Interleukin‐1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992; 79 (9): 2196–2200 [PubMed] [Google Scholar]
- 11. Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA: Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL‐18 and IL‐1 beta. Proc Natl Acad Sci USA 2001; 98: 2871–2876 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Deten A, Volz HC, Briest W, Zimmer HG: Differential cytokine expression in myocytes and non‐myocytes after myocardial infarction in rats. Mol Cell Biochem 2003; 242: 47–55 [PubMed] [Google Scholar]